"I'm wildly bullish, and I may be dead wrong, but I'm wildly bullish."
You know what they say: 'With great opportunity comes great risk.' That's exactly what I discovered when I stumbled upon the TSLY ETF. As an investor always looking for new prospects, I was drawn to the potential returns and volatility of Tesla's stock price that …
We're diving into the extraordinary growth of NVIDIA amidst the hurdles of export control regulations. NVIDIA's third quarter revenue soared to a staggering $18.1 billion, an astonishing 34% increase from the previous quarter and a remarkable 200% surge from the previous year. The demand for …
The US Steel board is currently at a crossroads as it faces a critical decision concerning various takeover bids. With multiple offers exceeding $40 per share, including a cash and stock bid from Cleveland-Cliffs and an all-cash bid from ArcelorMittal potentially reaching $45 per share, …
As an investor, I am intrigued by the fierce competition between two automotive titans: Ford and General Motors (GM). Did you know that combined, these companies sold over 7 million vehicles in the United States alone last year? With such impressive numbers, it's clear that …
In this article, we want to share with you the recent developments and strategic shifts of PacWest Bancorp. We understand that some may have concerns about the stability of their deposits, especially after the closure of two regional banks. However, we are pleased to inform …
Seeking Alpha, a prominent financial news and analysis platform, has made a significant policy change by breaking its paywall and offering free access to its premium articles. This new development, which took effect in January 2021, allows readers to access any article on any stock …
Stryker Corporation, a prominent player in the medical technologies industry, has garnered widespread attention due to its substantial market capitalization of over $100 billion. With its strong presence in the market, Stryker's revenue streams are primarily derived from its MedSurg & Neurotechnology division, accounting for …
In a surprising turn of events, Walmart's CEO has made a massive stock sale that has sent shockwaves through the market. This significant stock sale has raised questions and speculation about its potential impact on the company's stock performance and overall market perception. As one …
Geron's Imetelstat has emerged as a potential game-changer in the field of hematological cancers. Despite facing competition from other pharmaceutical companies and safety concerns regarding discontinuation rates, this telomerase inhibitor aims to halt the proliferation of malignant hematopoietic stem cells. Geron is the only company …
In the highly competitive arena of large-cap exchange-traded funds (ETFs), two formidable contenders have emerged: SCHX and VOO. Boasting total assets of over $29B and $264B respectively, these funds have established their credibility and size in the market. With SCHX tracking the Dow Jones US …